Nancy Thornberry serves as Executive at Denali Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Nancy Thornberry has executed 12 insider transactions totaling $693.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 18, 2024 involved receiving (via award) 5,000 shares valued at $0.
Nancy Thornberry currently holds 11,250 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Thornberry has been a net seller of DNLI stock. They have purchased $0 and sold $693.0K worth of shares.
Nancy Thornberry's most recent insider trade was on Jun 18, 2024, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 1, 2024 | VRTX | $0 | Award | 501 | $N/A | Discretionary |
| Dec 5, 2023 | VRTX | $0 | Award | 1,136 | $N/A | Discretionary |
| Jun 15, 2023 | SDGR | $0 | Award | 6,250 | $N/A | Discretionary |
| Jun 1, 2023 | DNLI | $0 | Award | 4,216 | $N/A | Discretionary |
| May 22, 2023 | SDGR | $519.8K | Sale | 14,850 | $35.00 | Discretionary |
| May 22, 2023 | SDGR | $171.1K | Option Exercise | 14,850 | $11.52 | Discretionary |
| Aug 11, 2022 | SDGR | $57.0K | Option Exercise | 4,950 | $11.52 | Discretionary |
| Aug 11, 2022 | SDGR | $173.3K | Sale | 4,950 | $35.00 | Discretionary |
| Jun 2, 2022 | DNLI | $0 | Award | 5,986 | $N/A | Discretionary |
| Jan 8, 2022 | DNLI | $0 | Award | 627 | $N/A | Discretionary |